The definitive benchmark for genitourinary dealmaking
Genitourinary partnering spans a range of oncology and non-oncology indications, with deal structures reflecting the diversity of development pathways, therapeutic approaches, and commercial strategies across the space.This report provides a comprehensive and structured analysis of 316 genitourinary collaboration and licensing deals, delivering a clear and evidence-based view of how partnerships are designed, negotiated, and executed across the market.
Establish a clear view of market standards
The report enables a precise understanding of how genitourinary deals are structured in practice, allowing you to:
- Benchmark comparable transactions with confidence
- Detailed analysis of upfronts, milestones, and royalty structures across relevant deals
- Define realistic market parameters
- Clear insight into how deal terms vary by stage, asset type, and partner profile
- Support valuation and structuring decisions with evidence
- Ground internal discussions in real transaction data rather than assumptions
- Understand how leading companies approach dealmaking
- Visibility into partner behaviour and recurring deal structures across a diverse therapeutic and commercial landscape
- Full visibility into deal structure and execution
This includes:
- Rights granted and retained
- Development and commercialization responsibilities
- Financial structures and payment triggers
- Key contractual provisions and protections
Designed for real-world BD and strategy use
The report is widely used to:
- Structure and benchmark live transactions
- Prepare for negotiations with well-defined market context
- Evaluate partnership opportunities and counterparties
- Support internal strategy with robust, defensible data
What’s included?
- 316 genitourinary collaboration and licensing deals
- Financial terms, including upfronts, milestones, and royalties where disclosed
- Fully searchable deal directory (by company, therapy, and technology)
- Direct access to SEC-filed agreements and source documents
- Analysis of deal trends, key transactions, and active dealmakers
- A trusted, evidence-based reference for genitourinary dealmaking
Table of Contents
Executive SummaryChapter 1 - Introduction
Chapter 2 - Trends in genitourinary dealmaking
Chapter 3 - Financial deal terms for genitourinary partnering
Chapter 4 - Leading genitourinary deals and dealmakers
Chapter 5 - Genitourinary contract document directory
Chapter 6 - Genitourinary dealmaking by therapeutic target
Deal directory
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 20/20 BioLabs
- Abbott Laboratories
- Abbvie
- Acer Therapeutics
- Acerus
- Acurx Pharmaceuticals
- AdaptivEndo
- Advanz Pharma
- Akcea Therapeutics
- Akebia Therapeutics
- Alberta Health Services
- Albert Einstein College of Medicine
- Alexion Pharmaceuticals
- Algernon Pharmaceuticals
- Alio Medical
- AliveCor
- Alivio Therapeutics
- Allecra Therapeutics
- Allergan
- Alloy Therapeutics
- Alnylam Pharmaceuticals
- Altasciences
- Altavant Sciences
- AM-Pharma
- Ambry Genetics
- American Lung Association
- American Renal Associates
- American Urological Association
- Amerigen Pharmaceuticals
- Amgen
- Amicus Therapeutics
- Ampio Pharmaceuticals
- Amplity Health
- Angion Biomedica
- Antares Pharma
- Anteris Bio
- Anthem
- Apellis Pharmaceuticals
- Aquestive Therapeutics
- Aquinox Pharmaceuticals
- Arch Biopartners
- Ardelyx
- Arena Pharmaceuticals
- Arrevus
- Ascend Clinical
- ASC Therapeutics
- Asieris Pharmaceuticals
- ASKA Pharmaceuticals
- Aspect Biosystems
- Assistance Publique-Hôpitaux de Paris
- Astek Diagnostics
- Astellas Pharma
- AstraZeneca
- Astute Medical
- Aurinia Pharmaceuticals
- AWAK Technologies
- Ayogo Health
- Aziyo Biologics
- Baxter International
- Bayer
- Baylor Health Care System
- Beacon Discovery
- Beckman Coulter
- Beijing Mabworks Biotech
- BenevolentAI
- Beth Israel Deaconess Medical Center
- Biim Ultrasound
- Bio-Techne
- BIOASTER
- Biocoat
- Biomedical Advanced Research and Development Authority
- bioMerieux
- Bioqube Ventures
- BioSerenity
- Blacksmith Medicines
- Blue Cross Blue Shield Association
- Blue Water Biotech
- Boehringer Ingelheim
- Bridge Medicines
- Brigham and Women's Hospital
- BrightInsight
- Bristol-Myers Squibb
- Caelum Biosciences
- Caldera Pharmaceuticals
- Calliditas Therapeutics
- CAMP4 Therapeutics
- Cantex Pharmaceuticals
- Cara Therapeutics
- CARB-X
- Cardio Renal Society of America
- CareDx
- CB2 Therapeutics
- CELLINK
- Centogene
- ChemoCentryx
- China Medical System
- Chinook Therapeutics
- Cigna Healthcare
- CJ Corp
- Cleveland Clinic
- Climb Bio
- Clinical Consultants International
- Clinical Laserthermia Systems (CLS)
- CloudCath
- Cogentix Medical
- Columbia University
- Cook Biotech
- Corino Therapeutics
- Cornell University
- Creative Medical Technologies
- Cricket Health
- CromSource
- CrossBay Medical
- CSL
- CytoSorbents
- Dalton Pharma Services
- Danish Innovation Fund
- Datavant
- DaVita
- Debiopharm
- Defense Threat Reduction Agency
- DemeTECH
- Department of Veterans Affairs
- Dialco Medical
- Dicerna Pharmaceuticals
- DILIsym Services
- Dimerix Biosciences
- Diurnal
- Drexel University
- Duchesnay
- Ecole Polytechnique Federale de Lausanne
- eGenesis
- EirGen Pharma
- Eledon Pharmaceuticals
- Elexopharm
- Eliaz Therapeutics
- Eli Lilly
- Enable Injections
- Enteris Biopharma
- Enzyvant Science
- Epigen Biosciences
- Erasmus University Medical Center
- Erlangen University Hospital
- Eton Pharmaceuticals
- Eurofins Scientific
- Everest Medicines
- Eversana
- Evestra
- Evotec
- Exagen Diagnostics
- ExCEEd Orphan
- Ferring Pharmaceuticals
- Fimbrion Therapeutics
- FirstString Research
- Flagship Pioneering
- Forendo Pharma
- Fortress Biotech
- Fosun Pharmaceutical
- Foundation for International Urogynecological Assistance
- Frazier Healthcare Ventures
- Frenova Renal Research
- Fresenius
- Fresenius Kabi Pharmaceuticals
- Fresenius Medical Care
- Fuji Yakuhin
- Fundacion Progreso y Salud
- Gedeon Richter
- Geisinger Medical Center
- Genewiz
- Genexo
- George Clinical
- Gilead Sciences
- Goldfinch Bio
- Great Bay Bio
- GSK
- Guangzhou Boji Medical Biotechnological
- Hangzhou Zhongmei Huadong Pharmaceutical
- Harvard Stem Cell Institute
- Harvard University
- Health Logic Interactive
- Helix BioPharma
- HemoCleanse
- Henlius Biotech
- HHS Technology Group
- HIBio
- Horizon Therapeutics
- Humana
- HydroCision
- Hyloris Pharmaceuticals
- Ibidi
- Icahn School of Medicine at Mount Sinai
- Ideal Medical Solutions
- IGAN Biosciences
- Ilias Biologics
- Immedica
- ImmuneID
- ImpediMed
- Innovation Network Corporation
- Innovus Pharmaceuticals
- Insilico Medicine
- IntelGenx
- Intelligent Scopes
- IntrinsiQ
- Inventia Healthcare
- Invitae
- InVivo
- Ion Channel Innovations
- Ionis Pharmaceuticals
- Itochu
- Jana Care
- Janssen Pharmaceuticals
- Janssen Research & Development
- Japan Tobacco
- JCR Pharmaceuticals
- Johns Hopkins University
- Jolt Health
- JSR
- Juventas Therapeutics
- Kahn-Sagol-Maccabi
- Kaken Pharmaceutical
- Karolinska Institute
- KBI BioPharma
- Keryx Biopharmaceuticals
- Key Technologies
- Kezar Life Sciences
- Kumamoto University
- Kyorin Pharmaceutical
- Kyowa Hakko Kirin
- Kyowa Hakko Kogyo
- Laborie Medical Technologies
- Lavasta Pharma
- Leiden University
- Lifeline Vascular Care
- LifeStrands Genomics
- Locus Biosciences
- Lupus Foundation of America (LFA)
- Lupus Research Alliance
- Lupus Therapeutics
- Luqa Pharmaceuticals
- Marathon Medical
- Massachusetts General Hospital
- Mathematica
- Mauna Kea Technologies
- Mayo Clinic
- Maze Therapeutics
- Medeologix
- MediBeacon
- Medical University South Carolina
- Medice Arzneimittel Pütter
- MedImmune
- Medinova
- Medipal Holdings
- Medison Pharma
- Medline Industries
- Melinta Therapeutics
- Memorial Sloan Kettering Cancer Center
- Menarini
- Merck Animal Health
- Merck Sharpe & Dohme
- Merz
- Mesh Bio
- Metabolon
- MetaSight Diagnostics
- Methuselah Foundation
- Metrion Biosciences
- Michigan Medicine
- MicrobeDx
- Mironid
- Mitobridge
- Morehouse School of Medicine
- MorphoSys
- Mount Sinai Health System
- MultiOmic Health
- Murdoch Childrens Research Institute
- Myovant Sciences
- Nanostics Precision Health
- NanoVibronix
- Nantes University
- Nashville Biosciences
- National Institute of Allergy and Infectious Diseases
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Institutes of Health
- National Institutes of Health Clinical Center
- National Kidney Foundation
- National Research Council Canada
- NCPC GeneTech
- Neokidney
- Nephria Bio
- Neptune Technologies & Bioressources
- Nestle Health Science
- NeuralStem
- Nicoya
- Nkarta Therapeutics
- NMI Natural and Medical Sciences Institute
- Nosopharm
- Novartis
- Novo Integrated Sciences
- Novo Nordisk
- Numares
- Oklahoma Medical Research Foundation
- OmniVision Technologies
- One Biosciences
- Onegevity
- OpGen
- OPKO Health
- Organovo
- OrsoBio
- OSE Immunotherapeutics
- Ospedale San Raffaele
- Otsuka
- Outpost Medicine
- Outset Medical
- Palette Life Sciences
- Palleon Pharmaceuticals
- Panion & BF Biotech
- Par Pharmaceutical
- PatenSee
- Patheon N.V.
- Penn State College of Medicine
- Perlara
- Pharmacological research Institute Mario Negri
- Pherecydes Pharma
- Pierre Fabre
- Pivotal bioVenture Partners
- Poiesis Medical
- PPD
- Precision Image Analysis
- Procept BioRobotics
- Promepla
- Promethera Biosciences
- Prometic Life Sciences
- Protalix BioTherapeutics
- Proteomics International
- Purdue Pharma
- PureTech Health
- PX Therapeutics
- Pythagoras Medical
- Q32 Bio
- Quebec Urological Association Foundation
- Quimica Europea
- Quotient Therapeutics
- Rambam Medical Center
- REACH Kidney Care
- Reata Pharmaceuticals
- Rebiotix
- ReCor Medical
- Rectify Pharmaceuticals
- Rediscovery Life Sciences
- Regulus Therapeutics
- Relief Therapeutics
- Renalys Pharma
- RenalytixAI
- Resverlogix
- ReviR Therapeutics
- Roche
- Roche Diagnostics
- Rockwell Medical
- ROi (Resource Optimization & Innovation)
- Roivant Sciences
- ROKIT Healthcare
- Royal Children’s Hospital
- Samsung Bioepis
- SandboxAQ
- Sanguina
- Saniona
- SanReno Therapeutics
- Sarfez Pharmaceuticals
- Satellite Healthcare
- Scanwell Health
- Scohia Pharma
- Scynexis
- Secarna Pharmaceuticals
- Selecta Biosciences
- Selexis
- Sequentify
- Shanghai Haini Pharmaceutical
- Siemens Healthineers
- Silence Therapeutics
- Singapore General Hospital
- SinoMab Bioscience
- Sinovant Sciences
- Somatus
- SOM Biotech
- Sonacare Medical
- Specialty Renal Products
- Spectrum Pharmaceuticals
- Spero Therapeutics
- Sphingotec
- Spruce Biosciences
- STADA Arzneimittel
- Stanford University
- Sumitomo Dainippon Pharma
- Sumitomo Pharmaceuticals
- Sumitovant Biopharma
- Sun Pharmaceutical
- Suzhou Sinovent Pharmaceuticals
- Swedish Orphan Biovitrum
- Swixx Biopharma
- SyMap Medical
- Sysmex America
- TaiGen Biotechnology
- Takeda Pharmaceutical
- Teijin
- Telara Pharma
- Telix Pharmaceuticals
- Terumo Blood and Cell Technologies
- Tetra Bio-Pharma
- Teva Pharmaceutical Industries
- The Medicines Company
- The United Laboratories
- Thoeris
- Thorne Research
- TONIX Pharmaceuticals
- toSense
- Travere Therapeutics
- Trestle Biotherapeutics
- Tufts Medical Center
- twoXAR
- TxCell
- Ubiquigent
- Unicycive Therapeutics
- Unilife
- University of Arkansas
- University of Bristol
- University of California
- San Diego
- University of California Berkeley
- University of California San Francisco
- University of Cambridge
- University of Glasgow
- University of Houston
- University of Massachusetts Medical School
- University of Miami
- University of Michigan
- University of Pennsylvania
- University of Sheffield
- University of Texas
- University of Texas at El Paso
- University of Toronto
- University of Utah
- University of Western Ontario
- UpScriptHealth
- Ur24Technology
- UroGen Pharma
- Urotronic
- Urovant Sciences
- US Air Force
- US Army Medical Research Institute of Infectious Diseases
- Vanderbilt University
- Vaneltix Pharma
- Varian Medical Systems
- Variant Bio
- VenatoRx
- Vensica Medical
- Ventus Therapeutics
- Verana Health
- Vertex Pharmaceuticals
- Viatris
- Vifor-Fresenius Medical Care Renal Pharma
- Vifor Pharma
- Vinnova
- VisiQuate
- Vizient
- vTv Therapeutics
- Weill Cornell Medical College
- Winhealth Pharma Group
- Worldwide Clinical Trials
- Wuxi Apptec Laboratory Services
- Xisle Pharma Ventures Trust
- Xortx Therapeutics
- Yeda Research and Development Company
- Yonsei University Severance Hospital
- Zai Lab
- Zhejiang Ausun Pharmaceutical
- Zifo
- Zydus Cadila
- ZyVersa Therapeutics
Methodology
- The publisher reports provide insight into the trends and terms of partnering deals in the global life sciences sector.
- The publisher reports are updated every six months to ensure the user has access to the latest announcements and trends in the topic focus of the report.
- The publisher analysts review the deal data to provide an overview and analysis of deal trends, including example deals and terms.
- The publisher reports source deal data from our proprietary deals and alliances database. The database is updated daily by our analysts with new deals as they are announced globally by the company’s party to the deal.
- The data in the deals and alliances database is obtained from secondary sources such as publicly available industry sources including press releases, company presentations, investor presentations, company SEC filings, other company filings, company websites, conference presentations. Sources are identified to allow for user verification.
The publisher provides comprehensive coverage of the following partnering or deal types:
- Asset purchase
- Assignment
- Co-development
- Co-market
- Co-promotion
- Collaborative R&D
- Contract service
- CRADA
- Cross-licensing
- Development
- Distribution
- Equity purchase
- Evaluation
- Grant
- Joint venture
- Licensing
- Loan
- Manufacturing
- Marketing
- Option
- Promotion
- Research
- Royalty financing
- Settlement
- Spin out
- Sub license
- Supply
- Termination
- Warrant
Every deal record is fully categorized and includes the following data, where available:
- Industry sector
- Therapy areas
- Technology type
- Deal components
- Financial terms
- Stage of development
- Exclusivity
- Asset type
- Geographic focus
- Excluded geography
- Company press release
- SEC filing data including contract document
All financial amounts are converted to US$ using the exchange rate available on the date of deal announcement, enabling direct comparison of deal terms across international territories.
LOADING...
